ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 273,12
2,37%
Dow Jones
40 524,79
0,78%
DAX
20 954,83
2,88%
Brent Oil
64,75
0,37%
Bitcoin
84 957,70
0,44%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) Actualités

LAB

Standard BioTools (LAB)

Standard BioTools Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LAB
DateHeureSourceTitreSymboleSociété
08/04/202522h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/03/202501h46Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LABStandard BioTools Inc
27/02/202522h01GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
26/02/202522h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
26/02/202522h01GlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
12/02/202513h00GlobeNewswire Inc.Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025NASDAQ:LABStandard BioTools Inc
13/01/202513h00GlobeNewswire Inc.Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 RevenueNASDAQ:LABStandard BioTools Inc
08/01/202513h00GlobeNewswire Inc.Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature MedicineNASDAQ:LABStandard BioTools Inc
19/12/202414h00GlobeNewswire Inc.Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LABStandard BioTools Inc
14/11/202421h32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LABStandard BioTools Inc
12/11/202422h13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LABStandard BioTools Inc
07/11/202414h00GlobeNewswire Inc.Standard BioTools Appoints Alex Kim as Chief Financial OfficerNASDAQ:LABStandard BioTools Inc
06/11/202423h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABStandard BioTools Inc
30/10/202421h01GlobeNewswire Inc.Standard BioTools Reports Third Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
24/10/202420h02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LABStandard BioTools Inc
16/10/202414h00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LABStandard BioTools Inc
24/09/202414h00GlobeNewswire Inc.Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K PlatformNASDAQ:LABStandard BioTools Inc
18/09/202414h00GlobeNewswire Inc.Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)NASDAQ:LABStandard BioTools Inc
03/09/202423h49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
26/08/202414h00GlobeNewswire Inc.Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:LABStandard BioTools Inc
15/08/202402h54Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LABStandard BioTools Inc
06/08/202422h39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
31/07/202422h02GlobeNewswire Inc.Standard BioTools Announces Senior Leadership ChangesNASDAQ:LABStandard BioTools Inc
31/07/202422h01GlobeNewswire Inc.Standard BioTools Reports Second Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
17/07/202414h01GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024NASDAQ:LABStandard BioTools Inc
03/06/202423h20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
03/06/202423h19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LABStandard BioTools Inc
29/05/202422h34Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LABStandard BioTools Inc
28/05/202422h01GlobeNewswire Inc.Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan CustomersNASDAQ:LABStandard BioTools Inc
21/05/202423h16Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB

Dernières Valeurs Consultées

USOTC
DBXXF
Xtrackers Stoxx Global S... (CE)
BIT
QFAL
DeA Capital Real Estate ...
BIT
P1PVU3
BNP Paribas Issuance
ASX
HACK
BetaShares Capital
BIT
UB593C
Unicredit Bank
TSXV
MMY
Monument Mining
DBI
0K5L
DAX TR GBP
LSE
SAZ
ASX
W2VO
Way 2 Vat
ASX
UWC
Underwood Capital
ASX
SPG
SPC Global
COIN
PORTOUSD
FC Porto Fan Token
COIN
UCASHUSD
U.CASH
ASX
LLL
Leo Lithium
COIN
WPCCCETH
WePiggy Coin
FX
DKKPHP
DKK vs PHP
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces